General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Operations

v3.10.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Operating Expenses        
Research and development costs $ 807,661 $ 139,922 $ 926,117 $ 1,536,996
General and administrative expenses 483,955 94,018    
Total operating expenses 1,291,616 233,940 1,802,433 1,921,520
Operating Loss (1,291,616) (233,940) (1,802,433) (1,921,520)
Other Income (Expense)        
Interest expense (87,740) (59,063)
Interest income 1,024 1,498 5,181 4,454
Total other income (expense) (86,716) 1,498 (53,882) 4,454
Net Operating Loss Before Income Tax Benefit (1,378,332) (232,442)    
Income Tax Benefit 281,534
Net Loss $ (1,096,798) $ (232,442) $ (1,856,315) $ (1,917,066)
Net Loss per Common Share - Basic and Diluted $ (0.03) $ (0.01) $ (0.06) $ (0.07)
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted 35,272,626 31,745,242 32,595,680 29,321,049